Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Other Working Capital Changes (2019 - 2025)

Korro Bio (KRRO) has disclosed Other Working Capital Changes for 6 consecutive years, with -$1.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Working Capital Changes fell 23.06% year-over-year to -$1.7 million, compared with a TTM value of $8.2 million through Sep 2025, up 2032.94%, and an annual FY2024 reading of $9.4 million, up 1786.05% over the prior year.
  • Other Working Capital Changes was -$1.7 million for Q3 2025 at Korro Bio, down from -$172000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $14.2 million in Q4 2021 and bottomed at -$12.8 million in Q3 2021.
  • Average Other Working Capital Changes over 5 years is $415473.7, with a median of -$172000.0 recorded in 2025.
  • The sharpest move saw Other Working Capital Changes plummeted 19234.33% in 2021, then skyrocketed 2333.41% in 2024.
  • Year by year, Other Working Capital Changes stood at $14.2 million in 2021, then crashed by 99.14% to $123000.0 in 2022, then plummeted by 443.09% to -$422000.0 in 2023, then surged by 2333.41% to $9.4 million in 2024, then plummeted by 118.18% to -$1.7 million in 2025.
  • Business Quant data shows Other Working Capital Changes for KRRO at -$1.7 million in Q3 2025, -$172000.0 in Q2 2025, and $617000.0 in Q1 2025.